Compare DSWL & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DSWL | NOTV |
|---|---|---|
| Founded | 1987 | 1974 |
| Country | Macau | United States |
| Employees | N/A | N/A |
| Industry | Plastic Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.7M | 29.9M |
| IPO Year | 1995 | 1997 |
| Metric | DSWL | NOTV |
|---|---|---|
| Price | $3.56 | $0.81 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 15.8K | ★ 1.6M |
| Earning Date | 11-13-2025 | 12-03-2025 |
| Dividend Yield | ★ 5.62% | N/A |
| EPS Growth | ★ 20.23 | N/A |
| EPS | ★ 0.78 | N/A |
| Revenue | $65,664,000.00 | ★ $513,024,000.00 |
| Revenue This Year | N/A | $6.26 |
| Revenue Next Year | N/A | $45.49 |
| P/E Ratio | $4.56 | ★ N/A |
| Revenue Growth | N/A | ★ 4.54 |
| 52 Week Low | $1.93 | $0.66 |
| 52 Week High | $4.48 | $6.48 |
| Indicator | DSWL | NOTV |
|---|---|---|
| Relative Strength Index (RSI) | 46.93 | 36.67 |
| Support Level | $3.53 | $0.84 |
| Resistance Level | $3.75 | $0.95 |
| Average True Range (ATR) | 0.17 | 0.12 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 22.65 | 39.36 |
Deswell Industries Inc is engaged in the manufacturing and selling of injection-molded plastic parts and components. In addition, it also offers manufacturing services for electronic products and subassemblies and manufactures metallic molds and accessory parts for original equipment manufacturers and contract manufacturers. The company conducts all of its manufacturing activities at separate plastics, electronics and metallic operation factories located in the People's Republic of China. It operates through the Plastic Injection Molding and Electronic Products Assembling segments. The firm offers products such as automobile components, medical testing equipment, parts for audio equipment, av receivers, active subwoofers, digital system key sets, communication products and others.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.